Background illustration for clinical trials search

Paid Clinical Trials Birmingham

Discover 889 paid clinical trials in Birmingham, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

for
Prostate Cancer
Location: Tuscaloosa AL, Atlanta GA, Memphis TN, Jackson MS,
Sponsor: Prostate Cancer Clinical Trials Consortium

Sex: Male

Age: 21+

Code: NCT03151629

Recruiting

Spices for Cultivating a Healthy Gut Microbiome and Cardiometabolic Profile

for
Cardiometabolic Syndrome
Location: Tuscaloosa AL
Sponsor: University of Alabama, Tuscaloosa

Sex: Female

Age: 50 - 69

Code: NCT06313580

Recruiting

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

for
Metastatic Colorectal Cancer (CRC)
Location: Tuscaloosa AL, Atlanta GA, Newnan GA, Hermitage TN,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT07228832

Phase3, Recruiting

The HOME Study (Healthy Options Made Easy): Telehealth Nutrition Sessions for People Living With Brain Injury

for
Brain Injuries
Location: Tuscaloosa AL
Sponsor: University of Alabama, Tuscaloosa

Sex: All

Age: 18+

Code: NCT05965947

Recruiting

Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)

for
HIV/AIDS
Location: Hobson City AL, Opelika AL, Jackson MS, New Orleans LA
Sponsor: Columbia University

Sex: All

Age: 18+

Code: NCT06472206

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.

for
Systemic Lupus Erythematosus,
Location: Anniston AL, Iowa City IA, Sherbrooke
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70

Code: NCT06916806

Phase1, Recruiting

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

for
Systemic Lupus Erythematosus
Location: Anniston AL, Lawrenceville GA, Jackson TN, Memphis TN,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT06133972

Phase3, Recruiting
FeaturedActive & Responsive

A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume

for
Mid Face Volume Deficit
Location: Birmingham AL, Atlanta GA, Metairie LA, Bradenton FL,
Sponsor: AbbVie

Sex: All

Age: 22+

Code: NCT06734351

Phase3, Recruiting
FeaturedActive & Responsive

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

for
Hypothyroidism
Location: Birmingham AL, Columbus GA, Chattanooga TN, Atlanta GA,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06345339

Phase2, Phase3, Recruiting
FeaturedActive & Responsive

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

for
Migraine
Location: Birmingham AL, Summerville SC, Tampa FL, Los Angeles CA,
Sponsor: AbbVie

Sex: All

Age: 18 - 70

Code: NCT06602479

Phase2, Recruiting
Featured

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

for
Atopic Dermatitis
Location: Birmingham AL, Columbus GA, Dawsonville GA,
Sponsor: AbbVie

Sex: All

Age: 18 - 63

Code: NCT06389136

Phase3, Recruiting
Active & Responsive

Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

for
Major Depressive Disorder
Location: Birmingham AL, Savannah GA, Jacksonville FL, Orlando FL,
Sponsor: Syndeio Biosciences, Inc

Sex: All

Age: 18 - 64

Code: NCT06547489

Phase2, Recruiting

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

for
Arrhythmia, Bradycardia, Heart Failure, Sinus Tachycardia
Location: Birmingham AL, Atlanta GA, Nashville TN, Germantown TN,
Sponsor: Medtronic

Sex: All

Age: 0+

Code: NCT00271180

Recruiting

Product Surveillance Registry

for
Cardiac Rhythm Disorders, Urological Disorders,
Location: Birmingham AL, Huntsville AL, Nashville TN,
Sponsor: Medtronic

Sex: All

Age: 0+

Code: NCT01524276

Recruiting

A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

for
Moderate-to-Severe Atopic Dermatitis
Location: Birmingham AL, Metairie LA, Savannah GA, Columbus OH,
Sponsor: Nektar Therapeutics

Sex: All

Age: 12+

Code: NCT07711418

Phase3, Recruiting

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

for
Heart Failure, Acute Heart Failure
Location: Birmingham AL, Huntsville AL, Atlanta GA, Duluth GA,
Sponsor: Colorado Prevention Center

Sex: All

Age: 18+

Code: NCT06008197

Phase3, Recruiting

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

for
Focal Segmental Glomerulosclerosis,
Location: Birmingham AL, Atlanta GA, Tampa FL, Chapel Hill NC,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT06500702

Phase2, Recruiting

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

for
LGLL - Large Granular Lymphocytic Leukemia,
Location: Birmingham AL, Tampa FL, Columbus OH,
Sponsor: Dren Bio

Sex: All

Age: 18+

Code: NCT05475925

Phase1, Phase2, Recruiting

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

for
Atopic Dermatitis
Location: Birmingham AL, Atlanta GA, Macon GA, Louisville KY,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06947993

Phase2, Recruiting

A Study of Olezarsen for the Treatment of Familial Chylomicronemia Syndrome (FCS) in Pediatric Participants

for
Familial Chylomicronemia Syndrome
Location: Birmingham AL, Dallas TX, Fort Worth TX,
Sponsor: Ionis Pharmaceuticals, Inc.

Sex: All

Age: 2 - 17

Code: NCT07727538

Phase3, Recruiting